Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence  Jane B. Taylor, Lisa A. Hogue, John J. LiPuma,

Slides:



Advertisements
Similar presentations
Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects  Masashi Tanaka, Yoshiyuki Matsuo,
Advertisements

Volume 176, Issue 5, Pages (November 2006)
Volume 16, Issue 4, Pages (October 2014)
Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans  Emma Caraher, Caroline.
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis  P. McNally, C. Coughlan,
CFTR stabilizes ENaC at the plasma membrane
Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin  George W. Agak, Stephanie.
by Leila M. Lopes Bezerra, and Scott G. Filler
Neil E. Alexis, Marianne S. Muhlebach, David B. Peden, Terry L. Noah 
Osteopontin is increased in cystic fibrosis and can skew the functional balance between ELR-positive and ELR-negative CXC-chemokines  Sandra Jovic, Medya.
D-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models  Daniel J. Fox, Morris D. Cooper, Cristian A.
Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A
Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa  Magnus Paulsson,
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.
Anti-inflammatory effect of miglustat in bronchial epithelial cells
Volume 70, Issue 6, Pages (September 2006)
Heleen Van Acker, Elisabeth Van Snick, Hans J. Nelis, Tom Coenye 
Z. Kopeikin, Z. Yuksek, H.-Y. Yang, S.G. Bompadre 
Volume 14, Issue 9, Pages (May 2004)
Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes  Nathan W. Schmidt, George W.
A. Holmberg, R. Lood, M. Mörgelin, B. Söderquist, E. Holst, M
Volume 11, Issue 6, Pages (June 2012)
Pathogenic Escherichia coli in inflammatory bowel diseases
Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone 
Pancreatic acinar cell dysfunction in CFTR−/− mice is associated with impairments in luminal pH and endocytosis  Steven D. Freedman, Horst F. Kern, George.
Jamaal L. Benjamin, Rhea Sumpter, Beth Levine, Lora V. Hooper 
Insights into primary immune deficiency from quantitative microscopy
Interaction of nanobacteria with cultured mammalian cells
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation  Venkateshwar Mutyam,
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death  Hilary Clay, Hannah E. Volkman,
Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter  Naseem Mushtaq, PhD, Majid Ezzati, PhD, Lucinda.
Volume 125, Issue 1, Pages (July 2003)
Yuxuan Miao, Guojie Li, Xiaoli Zhang, Haoxing Xu, Soman N. Abraham 
Curcumin and genistein additively potentiate G551D-CFTR
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking  Graeme W. Carlile, Renaud Robert, Julie Goepp, Elizabeth Matthes,
Volume 27, Issue 1, Pages (July 2007)
Controlled clinical trials in cystic fibrosis — are we doing better?
P.M. Keig, E. Ingham, P.A.R. Vandamme, K.G. Kerr 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Early inflammation in the airways of a cystic fibrosis foetus
The Journal of Cystic Fibrosis: Sunny perspectives
Volume 25, Issue 16, Pages (August 2015)
Regulation of Skin Microvasculature Angiogenesis, Cell Migration, and Permeability by a Specific Inhibitor of PKCα  Sirosh M. Bokhari, Lisa Zhou, Marvin.
Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin  George W. Agak, Stephanie.
Legionella Reveal Dendritic Cell Functions that Facilitate Selection of Antigens for MHC Class II Presentation  Annie L Neild, Craig R Roy  Immunity 
Direct comparison of in vitro susceptibility of wildtype clinical Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) to TOBI®
Transepithelial fluctuation analysis of chloride secretion
Scott Jennings, Hang Pong Ng, Guoshun Wang  Journal of Cystic Fibrosis 
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
R. Dekkers, L. A. W. Vijftigschild, A. M. Vonk, E. Kruisselbrink, K. M
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death  Hilary Clay, Hannah E. Volkman,
Volume 12, Issue 4, Pages (February 2002)
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Volume 99, Issue 8, Pages (October 2010)
Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight Junctions  Carolyn B. Coyne, Jeffrey M. Bergelson  Cell 
Translocation of a Vibrio cholerae Type VI Secretion Effector Requires Bacterial Endocytosis by Host Cells  Amy T. Ma, Steven McAuley, Stefan Pukatzki,
Volume 16, Issue 4, Pages (October 2014)
CFTR modulators and pregnancy: Our work has only just begun
Fig. 1. Mitochondrial internalization in cardiomyocytes.
Isolates from the NZ97/192 household interact differently with host respiratory epithelial 16HBE cells. Isolates from the NZ97/192 household interact differently.
CFTR, investigated with the two-electrode voltage-clamp technique: the importance of knowing the series resistance  Georg Nagel  Journal of Cystic Fibrosis 
Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis  Ahmet Z. Uluer, David A. Waltz, Leslie.
Uta Griesenbach, A. Christopher Boyd  Journal of Cystic Fibrosis 
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Translocation of a Vibrio cholerae Type VI Secretion Effector Requires Bacterial Endocytosis by Host Cells  Amy T. Ma, Steven McAuley, Stefan Pukatzki,
Naomi Balaban, Yael Gov, Arkady Bitler, Johan R. Boelaert 
Presentation transcript:

Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence  Jane B. Taylor, Lisa A. Hogue, John J. LiPuma, Michael J. Walter, Steven L. Brody, Carolyn L. Cannon  Journal of Cystic Fibrosis  Volume 9, Issue 1, Pages 36-43 (January 2010) DOI: 10.1016/j.jcf.2009.10.002 Copyright © 2009 Elsevier B.V. Terms and Conditions

Fig. 1 B. dolosa enters respiratory epithelial cells. A. Transmission electron micrograph (TEM) depicting entry of a clinical strain of B. dolosa bacterium into a CFT1-LCFSN, WT-CFTR expressing, respiratory epithelial cell. Note the alignment of the bacterium with a membrane protrusion which suggests microtubule and microfilament involvement. Scale bar indicates 1µm. B. TEM depicting intracellular perinuclear vacuoles, which have been associated with microtubular trafficking, containing a clinical strain of B. dolosa in a CFT1-LCFSN cell. Both images were obtained after 6 hours of incubation with bacteria at an MOI of 15. Scale bar=4µm. Journal of Cystic Fibrosis 2010 9, 36-43DOI: (10.1016/j.jcf.2009.10.002) Copyright © 2009 Elsevier B.V. Terms and Conditions

Fig. 2 Affect of microfilament and microtubular inhibition on B. cenocepacia and B. dolosa entry into respiratory epithelial cells. A. Entry of B. cenocepacia into CFT1-LCFSN, WT-CFTR expressing cells incubated with either vehicle, the microtubule inhibitor colchicine (colch) or the actin filament inhibitor cytochalasin D (cytoD). B. Entry of B. dolosa into CFT1-LCFSN cells. C. Entry of B. cenocepacia into 16HBE, WT-CFTR expressing cells. D. Entry of B. dolosa into 16HBE cells. Bacterial entry is significantly reduced (p<0.05) with microtubule and actin filament inhibition in all cell lines with both bacterial isolates. Journal of Cystic Fibrosis 2010 9, 36-43DOI: (10.1016/j.jcf.2009.10.002) Copyright © 2009 Elsevier B.V. Terms and Conditions

Fig. 3 Cell ultrastructural change induced by B. dolosa in the presence and absence of functional CFTR. Entry of B. dolosa bacterium into WT-CFTR expressing CFT1-LCFSN cells (A. and B.) and ΔF508-CFTR expressing CFT1-LC3 cells (C. and D.). Note the more numerous cellular projections emanating from the CFT1-LCFSN surface and aligning with entering bacterium, as compared to the sparse cellular projections of the CFT1-LC3 cells. All scale bars=1µm. Journal of Cystic Fibrosis 2010 9, 36-43DOI: (10.1016/j.jcf.2009.10.002) Copyright © 2009 Elsevier B.V. Terms and Conditions

Fig. 4 B. dolosa invasion efficiency changes with MOI and CFTR expression. A. Entry of B. cenocepacia into CFT1-LCFSN (WT-CFTR) and CFT1-LC3 (ΔF508-CFTR) cells (p>0.05). B. Entry of B. dolosa into CFT1-LCFSN and CFT1-LC3 cells (p<0.05). Per cent change in entry frequency of B. dolosa over differing MOIs in C. CFT1-LCFSN (WT-CFTR) and D. CFT1-LC3 (ΔF508-CFTR) respiratory epithelial cells. The insert in panel D depicts the same information on an expanded Y axis. Journal of Cystic Fibrosis 2010 9, 36-43DOI: (10.1016/j.jcf.2009.10.002) Copyright © 2009 Elsevier B.V. Terms and Conditions

Fig. 5 Similar adherence of B. dolosa to WT-CFTR and ΔF508-CFTR expressing epithelial cells. CFT1-LCFSN (WT-CFTR, panels A. and B.) and CFT1-LC3 cells (ΔF508-CFTR, panels C. and D.) stained with Giemsa in order to visualize bacteria. Scale bar=10µm. Cells shown in panels A. and C. are uninfected; cells in panels B. and D. were incubated for 1h with 105CFU of B. dolosa prior to washing and staining. Arrowheads point to clumps of adherent bacteria. Panel E. depicts the results of 3 separate quantitative adhesion assays performed in triplicate. Data are presented as mean and standard deviation. No statistical difference was found between the two groups (p>0.5). Journal of Cystic Fibrosis 2010 9, 36-43DOI: (10.1016/j.jcf.2009.10.002) Copyright © 2009 Elsevier B.V. Terms and Conditions